Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Liver Transplant Infection”

94 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 94 results

Not applicableStudy completedNCT03389360
What this trial is testing

Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant

Who this might be right for
Liver Transplant Infection
National Hepatology & Tropical Medicine Research Institute 60
Testing effectiveness (Phase 2)Looking for participantsNCT06619561
What this trial is testing

Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Who this might be right for
Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC 48
Testing effectiveness (Phase 2)Study completedNCT02138253
What this trial is testing

A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV

Who this might be right for
Liver FibrosisHepatic FibrosisLiver Cirrhosis+1 more
Conatus Pharmaceuticals Inc. 64
Not applicableUnknownNCT05852964
What this trial is testing

Inflammatory and Anti-Inflammatory Gene Expressions in Liver Transplant Patients

Who this might be right for
Liver Transplant; ComplicationsInfectionsGene Amplification+1 more
Inonu University 54
Large-scale testing (Phase 3)Study completedNCT02032875
What this trial is testing

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 116
Large-scale testing (Phase 3)Not Yet RecruitingNCT06888479
What this trial is testing

Optimal Timing of Hepatitis B Vaccination After Transplants

Who this might be right for
Transplant-Related DisorderHepatitis B Virus InfectionVaccine Reaction
Institute of Hematology & Blood Diseases Hospital, China 1,500
Post-approval studies (Phase 4)Study completedNCT03619837
What this trial is testing

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

Who this might be right for
Hepatitis CTransplantation Disease Transmission
University of California, San Francisco 122
Not applicableStudy completedNCT06736093
What this trial is testing

Effect of Preoperative Vitamin D Supplementation in Liver Transplant Recipients With Vitamin D Deficiency on Post Transplant Outcomes

Who this might be right for
Post Liver Transplant Infection
Institute of Liver and Biliary Sciences, India 140
Not applicableUnknownNCT01944527
What this trial is testing

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

Who this might be right for
HCV RecurrenceLiver TransplantationDirect-acting Antiviral Agents
ANRS, Emerging Infectious Diseases 699
Large-scale testing (Phase 3)Study completedNCT00469131
What this trial is testing

Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

Who this might be right for
Hepatitis CLiver Cirrhosis
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 79
Not applicableLooking for participantsNCT06782880
What this trial is testing

Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation

Who this might be right for
Fecal Microbiota TransplantationOrthotopic Liver TransplantationMulti-drug Resistant Bacteria
IRCCS Azienda Ospedaliero-Universitaria di Bologna 144
Post-approval studies (Phase 4)Study completedNCT00998426
What this trial is testing

Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients

Who this might be right for
Hepatitis B
Georgetown University 5
Not applicableLooking for participantsNCT06715046
What this trial is testing

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD - Graft-Versus-Host DiseaseInfections After HSCTTransplant Associated Microangiopathy TAM+2 more
University of Turin, Italy 30
Post-approval studies (Phase 4)Ended earlyNCT03723824
What this trial is testing

Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation

Who this might be right for
Chronic Hepatitis cLiver Transplant InfectionKidney Transplant Infection
Taichung Veterans General Hospital 14
Not applicableUnknownNCT01139203
What this trial is testing

Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis B
Shanghai Jiao Tong University School of Medicine 300
Large-scale testing (Phase 3)Looking for participantsNCT05686759
What this trial is testing

Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.

Who this might be right for
Hepatitis B
GC Biopharma Corp 105
Post-approval studies (Phase 4)Ended earlyNCT00260208
What this trial is testing

Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

Who this might be right for
Liver TransplantHepatitis C
Novartis Pharmaceuticals 361
Testing effectiveness (Phase 2)Study completedNCT01687270
What this trial is testing

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

Who this might be right for
Recurrent Chronic Hepatitis C VirusPost Liver Transplant
Gilead Sciences 40
Post-approval studies (Phase 4)WithdrawnNCT03315052
What this trial is testing

Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects

Who this might be right for
Acute Cellular Graft RejectionLiver Transplant Rejection
Montefiore Medical Center
Post-approval studies (Phase 4)UnknownNCT04728971
What this trial is testing

To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver Transplantation

Who this might be right for
Liver Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 200
Next Page